Literature DB >> 31365297

The N6-methyladenosine (m6A)-forming enzyme METTL3 facilitates M1 macrophage polarization through the methylation of STAT1 mRNA.

Yihan Liu1,2, Zhujiang Liu1,2, Hao Tang3, Yicong Shen1,2, Ze Gong1,2, Nan Xie1,2, Xu Zhang1,2, Wengong Wang3, Wei Kong1,2, Yuan Zhou4, Yi Fu1,2.   

Abstract

Compelling evidence indicates that epigenetic regulations orchestrate dynamic macrophage polarization. N6-methyladenosine (m6A) methylation is the most abundant epigenetic modification of mammalian mRNA, but its role in macrophage polarization is still completely unknown. Here, we show that the m6A-catalytic enzyme methyltransferase like 3 (METTL3) is specifically upregulated following the M1 polarization of mouse macrophages. Furthermore, METTL3 knockdown through siRNA transfection markedly inhibited M1, but enhanced M2, macrophage polarization. Conversely, its overexpression via plasmid transfection greatly facilitated M1, but attenuated M2, macrophage polarization. Further methylated RNA immunoprecipitation and in vitro m6A methylation assays suggested that METTL3 directly methylates mRNA encoding signal transducer and activator of transcription 1 (STAT1), a master transcription factor controlling M1 macrophage polarization, at its coding sequence and 3'-untranslated regions. In addition, METTL3-mediated STAT1 mRNA methylation significantly increased mRNA stability and subsequently upregulated STAT1 expression. In conclusion, METTL3 drives M1 macrophage polarization by directly methylating STAT1 mRNA, potentially serving as an anti-inflammatory target.

Entities:  

Keywords:  METTL3; m6A methylation; macrophage polarization

Mesh:

Substances:

Year:  2019        PMID: 31365297     DOI: 10.1152/ajpcell.00212.2019

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  42 in total

Review 1.  RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.

Authors:  Subhadra Kumari; Santosh Kumar; Srinivasan Muthuswamy
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

Review 2.  Impact of N6-methyladenosine (m6A) modification on immunity.

Authors:  Raghda A Elsabbagh; Mona Rady; Carsten Watzl; Khaled Abou-Aisha; Mohamed Z Gad
Journal:  Cell Commun Signal       Date:  2022-09-09       Impact factor: 7.525

3.  METTL3-mediated macrophage exosomal NEAT1 contributes to hepatic fibrosis progression through Sp1/TGF-β1/Smad signaling pathway.

Authors:  Bo Shu; Rui-Zhi Zhang; Ying-Xia Zhou; Chao He; Xin Yang
Journal:  Cell Death Discov       Date:  2022-05-19

Review 4.  The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.

Authors:  Ze Zhang; Furong Liu; Wei Chen; Zhibin Liao; Wanguang Zhang; Bixiang Zhang; Huifang Liang; Liang Chu; Zhanguo Zhang
Journal:  Exp Hematol Oncol       Date:  2022-05-19

5.  METTL3 induces bone marrow mesenchymal stem cells osteogenic differentiation and migration through facilitating M1 macrophage differentiation.

Authors:  Hong Lei; Mingyu He; Xiaoqi He; Guanghui Li; Yang Wang; Yuelin Gao; Gege Yan; Quan Wang; Tao Li; Guoxin Liu; Weijie Du; Ye Yuan; Lei Yang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 6.  N6-Methyladenosine Regulates Host Responses to Viral Infection.

Authors:  Michael J McFadden; Stacy M Horner
Journal:  Trends Biochem Sci       Date:  2020-12-09       Impact factor: 13.807

7.  Involvement of METTL3/m6Adenosine and TGFβ/Smad3 signaling on Tenon's fibroblasts and in a rabbit model of glaucoma surgery.

Authors:  Yan Liu; Chao Gu; Xiabin Li; Tingwei Wang; Ling Yu
Journal:  J Mol Histol       Date:  2021-11-02       Impact factor: 2.611

Review 8.  Potential roles of N6-methyladenosine (m6A) in immune cells.

Authors:  Chang Liu; Zhe Yang; Rong Li; Yanju Wu; Ming Chi; Shuting Gao; Xun Sun; Xin Meng; Biao Wang
Journal:  J Transl Med       Date:  2021-06-08       Impact factor: 5.531

9.  m6A Regulator-Associated Modification Patterns and Immune Infiltration of the Tumor Microenvironment in Hepatocarcinoma.

Authors:  Jianhao Li; Weiwei Wang; Yubing Zhou; Liwen Liu; Guizhen Zhang; Kelei Guan; Xichun Cui; Xin Liu; Maoxin Huang; Guangying Cui; Ranran Sun
Journal:  Front Cell Dev Biol       Date:  2021-07-02

10.  The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ.

Authors:  Xia Wang; Yuge Ji; Panpan Feng; Rucheng Liu; Guosheng Li; Junjie Zheng; Yaqiang Xue; Yaxun Wei; Chunyan Ji; Dawei Chen; Jingxin Li
Journal:  Adv Sci (Weinh)       Date:  2021-05-03       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.